The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquila En Regulatory News (AEET)

Share Price Information for Aquila En (AEET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 62.75
Bid: 61.00
Ask: 64.50
Change: -0.50 (-0.79%)
Spread: 3.50 (5.738%)
Open: 64.50
High: 64.50
Low: 62.75
Prev. Close: 63.25
AEET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

28 Feb 2023 15:36

RNS Number : 3877R
Aquila Energy Efficiency Trust PLC
28 February 2023
 

28 February 2023

 

AQUILA ENERGY EFFICIENCY TRUST PLC

 

Result of General Meeting

 

Aquila Energy Efficiency Trust plc (the "Company") announces that, as previously anticipated in its announcement on 27 February 2023, the resolutions put forward at its General Meeting held earlier today did not pass. Resolution 1 was proposed as an ordinary resolution, requiring in excess of 50% of votes cast to be cast in favour to pass, and, Resolution 2 as a special resolution, requiring 75% of votes cast to be cast in favour to pass.

 

The text of the resolutions is contained in the Notice of General Meeting dated 13 February 2023, which can be found on the Company's website at https://www.aquila-energy-efficiency-trust.com.

 

Voting on the resolutions was taken on a poll. The results of the poll were as follows:-

 

Resolution

In favour

 

Against

Withheld

Votes

% Votes Cast

Votes

% Votes Cast

Votes

1

37,257,050

44.45

46,553,793

55.55

0

2

49,858,678

59.50

33,933,709

40.50

18,456

 

 

At the time of the above meeting, the Company's issued share capital consisted of 100,000,000 ordinary shares. The Company held no shares in treasury. Therefore, the total number of ordinary shares with voting rights was 100,000,000. Each ordinary share held entitles the holder to one vote and there are no restrictions on those voting rights. A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against" a resolution.

 

In accordance with the Company's Articles of Association, by 28 August 2023, being six months following the date of the General Meeting, the Directors will recommend to shareholders whether the Company be reconstructed, re-organised or placed into liquidation, having explored all options and determined the best solution including discussing the options with the Company's shareholders. In addition, as it stands, a further continuation vote will be required to be proposed at the Company's annual general meeting in 2023 (such meeting to be held no later than 30 June 2023) in accordance with the requirements of the Company's Articles of Association. A further announcement will be made in due course.

 

In light of the results of the General Meeting, the Investment Adviser no longer intends to undertake the acquisition of ordinary shares of the Company in the market, as previously disclosed in the Company's announcement released on 20 February 2023.

 

 

Enquiries:

Aquila Capital (Investment Adviser) 

 

Via Buchanan

Buchanan (Financial PR)

Charles Ryland, Henry Wilson, George Beale

 

020 7466 5000

Peel Hunt (Broker)

Luke Simpson, Huw Jeremy (Investment Banking)

 

020 7418 8900

Apex Listed Companies Services (UK) Limited (Company Secretary)

Maria Matheou, Brian Smith

020 3327 9720

 

 

LEI: 213800AJ3TY3OJCQQC53

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMEVLFLXLLXBBL
12
Date   Source Headline
19th Apr 20249:55 amRNSProposed Tender Offer
6th Mar 20242:45 pmRNSUnaudited NAV and Return of Capital
19th Jan 20242:00 pmRNSUpdate re: Investment Adviser
16th Nov 202310:54 amRNSDirector Declaration
27th Sep 20237:00 amRNSHalf-year Report
25th Sep 20234:00 pmRNSHolding(s) in Company
16th Aug 20237:00 amRNSShareholder Update
11th Aug 20237:00 amRNSNet Asset Value as at 30 June 2023
14th Jun 20235:21 pmRNSResult of AGM
2nd May 20237:01 amRNSNotice of AGM
2nd May 20237:00 amRNSFinal Results
13th Apr 20231:28 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSAppointment of Sole Corporate Broker
28th Feb 20233:36 pmRNSResult of General Meeting
27th Feb 20231:24 pmRNSGeneral Meeting Update on Proxy Votes
20th Feb 20237:00 amRNSPurchase of shares in relation to inv.advisory fee
16th Feb 20237:01 amRNSDividend Declaration
16th Feb 20237:00 amRNSNAV and Fact Sheet as at 31 December 2022
13th Feb 20237:00 amRNSPublication of Circular
30th Jan 20237:00 amRNSPositive Investment Update
17th Jan 20237:00 amRNSChange of Name of Company Secretary
20th Dec 20225:32 pmRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSTrading Update
13th Dec 20224:03 pmRNSDirector/PDMR Shareholding
3rd Nov 20225:31 pmRNSChange of AIFM's Name
3rd Nov 20227:00 amRNSDividend Declaration
2nd Nov 202211:58 amRNSAppointment of Non-executive Director
15th Sep 20224:22 pmRNSPurchase of shares re investment advisory fees
15th Sep 20227:00 amRNSDividend Declaration
15th Sep 20227:00 amRNSHalf-year Report
12th Aug 20225:55 pmRNSHolding(s) in Company
12th Aug 20227:00 amRNSFactsheet as at 30 June 2022
12th Aug 20227:00 amRNSNet Asset Value(s)
25th Jul 20222:06 pmRNSResult of General Meeting
25th Jul 20227:00 amRNSTrading Update
29th Jun 20225:03 pmRNSDirector/PDMR Shareholding
28th Jun 20224:30 pmRNSResult of AGM
28th Jun 20224:06 pmRNSPurchase of shares re investment advisory fees
24th Jun 20227:00 amRNSAnnual Financial Report
1st Jun 20227:00 amRNSNotice of AGM
29th Apr 20227:00 amRNSAppointment of Non-executive Director
21st Apr 20227:00 amRNSResult of Investment Strategy Review
23rd Feb 20223:15 pmRNSHolding(s) in Company
17th Feb 20227:00 amRNSFactsheet as at 31 December 2021
31st Jan 20227:00 amRNSCompany Update
6th Dec 20214:55 pmRNSChange of Registered Office
21st Oct 20217:00 amRNSReduction of the share premium account
17th Sep 20216:16 pmRNSHolding(s) in Company
28th Jun 20213:23 pmRNSHolding(s) in Company
28th Jun 20213:18 pmRNSHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.